trial · primary record
Zongertinib
Liver Diseases
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 29 |
| Primary completion | 2025-06-20 |
| Primary endpoint | Area Under the Concentration-time Curve of Zongertinib in Plasma Over the Time Interval From 0 Extrapolated to Infinity (AUC0-∞) |
| Registry ID | NCT06692322 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:05.912Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06692322
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Zongertinib · approval
- Zongertinib · compound